About Aillis
Aillis is a company based in Chuo (Japan) founded in 2017 by Hiroaki Kato and Sho Okiyama. Aillis has raised $36.31 million across 3 funding rounds from investors including SEGA SAMMY HOLDINGS, Japanet Takata and ALHD. Aillis operates in a competitive market with competitors including Tangen Biosciences, Hygiena, Prestodiag, Sanolla and Dawatek, among others.
- Headquarter Chuo, Japan
- Founders Hiroaki Kato, Sho Okiyama
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$36.31 M (USD)
in 3 rounds
-
Latest Funding Round
$3.3 M (USD), Series D
Nov 29, 2024
-
Investors
SEGA SAMMY HOLDINGS
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aillis
Aillis has successfully raised a total of $36.31M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $3.3 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aillis
Aillis has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include SEGA SAMMY HOLDINGS, Japanet Takata and ALHD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Television shopping and e-commerce services are provided by Japanet Takata.
|
Locked | Locked | Locked | |
|
Provider of services to comics gaming
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Aillis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aillis
Investment portfolio details for Aillis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aillis
Detailed financials for Aillis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aillis Comparisons
Peer comparison for Aillis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aillis
Aillis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tangen Biosciences, Hygiena, Prestodiag, Sanolla and Dawatek, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a molecular diagnostics platform
|
|
| Locked | Locked | Locked |
Manufacturer of hygiene monitoring systems
|
|
| Locked | Locked | Locked |
Utilizes surface plasmon resonance technology for pathogen detection.
|
|
| Locked | Locked | Locked |
AI-based digital diagnostics systems are developed for multiple disease detection.
|
|
| Locked | Locked | Locked |
Developer of medical imaging devices to diagnose infectious and chronic diseases
|
Detailed competitors of Aillis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aillis
Complete news archive for Aillis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aillis
Aillis was founded in 2017 and raised its 1st funding round 7 years after it was founded.
Aillis is headquartered in Chuo, Japan. It is registered at Chuo, Tokyo, Japan.
Sho Okiyama is the current CEO of Aillis. They have also founded this company.
Aillis is a funded company, having raised a total of $36.31M across 3 funding rounds to date.
Aillis was founded in 2017 in Chuo, Japan, within the healthcare technology sector. A medical device for detecting influenza viruses is developed, relying on AI and machine learning. Pharyngeal images from patients are analyzed to identify follicle characteristics, including surface color, gloss, size, and shapes on the posterior pharyngeal wall. Operations focus on diagnostic accuracy for infected individuals.
Aillis's top competitors include Hygiena, Definitive Biotechnologies and Tangen Biosciences.
Aillis has 3 investors. Key investors include SEGA SAMMY HOLDINGS, Japanet Takata, and ALHD.